ENTASIS THERAPEUTICS HOLDINGS INC. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/91ea3ec9-f0e1-45f5-bfee-04ea30d68663/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-47.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002788 |
| FY 2020 | $-50.5M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003348 |
| FY 2019 | $-43.9M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002414 |
| FY 2018 | $-33.0M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-002588 |
| FY 2017 | $-29.9M | 2017-01-01 – 2017-12-31 | evidence 0001558370-19-002588 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENTASIS THERAPEUTICS HOLDINGS INC. — all facts · Operating Income